Kim C H, Broxmeyer H E
Department of Microbiology/Immunology, Walther Oncology Center, Indiana University School of Medicine, Indianapolis 46202, USA.
J Leukoc Biol. 1999 Sep;66(3):455-61. doi: 10.1002/jlb.66.3.455.
Chemokines induce chemotaxis of hematopoietic progenitor cells (HPC), and suppress their proliferation. In this study we report that SLC/ Exodus2/6Ckine/TCA4 (hereafter termed SLC) is a chemoattractant for human CD34+ HPC. SLC mainly induces preferential chemotaxis of macrophage progenitors. We examined the chemotactic activity of CXCR3 ligands on CD34+ HPC because it has been reported that SLC is a potential ligand of CXC chemokine receptor, CXCR3, in addition to a CC chemokine receptor, CCR7. It was found that the CXCR3 ligands, MIG and interferon-gamma inducible protein-10 (IP-10), unlike SLC, did not induce chemotaxis of CD34+ HPC. In this regard, CCR7 ligands (SLC and CKbeta-11), but not IP-10 and MIG, induce actin polymerization in CD34+ cells. On the other hand, CCR7 ligands and CXCR3 ligands, but not the CXCR4 ligand SDF-1, showed inhibitory activity for proliferation of myeloid progenitor cells. Our results suggest that SLC is a potential trafficking factor for HPC, and that chemokines that bind CCR7, CXCR4, and CXCR3 have differential biological activities on HPC in terms of suppression and chemotaxis.
趋化因子可诱导造血祖细胞(HPC)的趋化作用,并抑制其增殖。在本研究中,我们报告称SLC/Exodus2/6Ckine/TCA4(以下简称SLC)是人类CD34+HPC的一种化学引诱剂。SLC主要诱导巨噬细胞祖细胞的优先趋化作用。我们检测了CXCR3配体对CD34+HPC的趋化活性,因为据报道,SLC除了是CC趋化因子受体CCR7的潜在配体外,还是CXC趋化因子受体CXCR3的潜在配体。结果发现,与SLC不同,CXCR3配体MIG和干扰素-γ诱导蛋白10(IP-10)不会诱导CD34+HPC的趋化作用。在这方面,CCR7配体(SLC和CKbeta-11)而非IP-10和MIG可诱导CD34+细胞中的肌动蛋白聚合。另一方面,CCR7配体和CXCR3配体而非CXCR4配体SDF-1对髓系祖细胞的增殖具有抑制活性。我们的结果表明,SLC是HPC的一种潜在转运因子,并且结合CCR7、CXCR4和CXCR3的趋化因子在抑制和趋化方面对HPC具有不同的生物学活性。